Back to News
Market Impact: 0.28

IREN: ARR Could Grow 6.8x To $3.4B By Year-End 2026 (NASDAQ:IREN)

IRENMSFTSOXL
Artificial IntelligenceTechnology & InnovationCorporate Guidance & OutlookCompany FundamentalsCorporate EarningsBanking & LiquidityAnalyst InsightsAnalyst Estimates
IREN: ARR Could Grow 6.8x To $3.4B By Year-End 2026 (NASDAQ:IREN)

IREN’s investment case centers on an AI Cloud ramp anchored by a $9.7 billion Microsoft agreement that targets $1.9 billion ARR and a company-wide AI Cloud ARR goal of $3.4 billion by end-FY2026; the firm argues its power-contract “moat” (2.91GW secured power, including 2.75GW in West Texas) can support 140k GPUs by 2026 while using only ~16% of that capacity. The AI Cloud business remains nascent—Q1 FY26 accounted for just 3% of consolidated revenue—but liquidity was boosted to $1.8 billion after $1.0 billion of zero-coupon converts, $200 million of GPU financing and $618.4 million raised via an ATM (now depleted). Trades at roughly 43x next year’s earnings and the Microsoft deal is milestone-based, so execution delays or dilution—especially at the Texas sites—pose material downside to the $3.4 billion ARR target; the analyst is cautiously optimistic and attributes recent share weakness largely to beta-driven moves.

Analysis

The investment case centers on IREN's AI Cloud ramp anchored by a $9.7 billion Microsoft agreement that targets $1.9 billion in ARR and a company-wide AI Cloud ARR goal of $3.4 billion by end-FY2026. The firm highlights a power-contract moat—2.91GW secured power (including 2.75GW in West Texas)—and projects 140k GPUs by 2026 that would consume only ~16% of that capacity, but AI Cloud was just 3% of consolidated revenue in Q1 FY26, emphasizing the early-stage nature of the business. Liquidity rose to $1.8 billion after $1.0 billion of zero‑coupon converts, $200 million of GPU financing and $618.4 million raised via an ATM program that is now depleted, yet the capital mix creates dilution risk tied to milestone funding. The stock trades at roughly 43x next year’s earnings, implying high execution expectations are already priced in and increasing sensitivity to misses. Primary downside drivers are execution slippage at Texas sites and milestone shortfalls on the Microsoft contract; the analyst labels recent weakness as largely beta-driven but remains cautiously optimistic. Near-term proof points—GPU deployment cadence, Microsoft milestone receipts, and any further financing—will be determinative for the valuation trajectory.